
The shareholder letter by Two Seas Capital says the buyout offer undervalues Core Scientific’s business.

The shareholder letter by Two Seas Capital says the buyout offer undervalues Core Scientific’s business.
Ultricies augue id venenatis at egestas aenean semper ac lectus praesent consequat.